U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioids.
Suzetrigine (Journavx) is the first new drug approved to treat acute pain in over 20 years and the first to be classified as ...
The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. The Food and Drug ...
Jenny Mosley's brother sadly died after being diagnosed with oesophageal cancer, and when her partner mentioned he had ...
Vertex Pharmaceuticals has scored an FDA approval for Journavx (suzetrigine), a non-opioid pain reliever that could usher in a new era of non-addictive therapy in the indication. As an oral ...
Jenny Mosley, 56, lost her brother Ade, 53, in October 2018, after he was diagnosed with oesophageal cancer - six months ...
Jenny Mosley, 56, lost her brother Ade, 53, in October 2018, after he was diagnosed with oesophageal cancer - but she ...
A MAN’S life was saved by his brother-in-law – after his wife recognised his persistent heartburn could be cancer too. Jenny ...
A man's life was saved by his brother-in-law after his wife recognised his persistent heartburn could be cancer too. Jenny ...
Certain drinks may soothe acid reflux symptoms and promote better digestion. Here are some expert-recommended options: ...